Cell Reports Medicine
Volume 1, Issue 1, 21 April 2020, 100005
ArticleThe Clinical Drug Ebselen Attenuates Inflammation and Promotes Microbiome Recovery in Mice after Antibiotic Treatment for CDI
Under a Creative Commons license
open access
Graphical Abstract
Keywords
ebselen
microbiome diversity
antibitoic treatment
vancomycin
clostridium difficile
microbiome recovery
anti-toxin
microbial dysbiosis
Cited by (0)
- 5
Lead Contact
© 2020 The Author(s).